foxo4-dri peptide senolytic 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI (Proxofim) (10mg)
FOXO4 DRI (Proxofim) (10mg) FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 D Retro Inverso(DRI) peptide FOXO4 DRI 10mg Ion Peptide FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




